According to a January 5, 2026 announcement from Ro, the direct-to-patient healthcare company has integrated directly with Novo Nordisk to offer what the platform describes as "the lowest available cash pay price" for the new oral formulation
Why are the names used interchangeably
For example, those who are candidates for Wegovy meet the FDA requirements of having a BMI (body mass index) of 30 or moreor 27 or more with a weight-related complication, such as hypertension or [high cholesterol], says Tom Wadden, Ph.D., a psychologist and professor at University of Pennsylvania, in Philadelphia, who studies obesity treatments
Regence does not cover Mounjaro for weight loss
The duration of Semaglutide GLP-1 treatment for weight loss depends on various factors, including the individuals weight loss goals, response to the medication, and overall health
With its ability to address both appetite and glucose regulation, semaglutide has proven an effective weight-loss option